The new lente insulins. 1953

M I DRURY

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D061405 Insulin, Lente An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage. Insulin Novo Monotard,Insulin, Lente, Monocomponent,Insulin, Monotard,Lente Insulin,Monotard Insulin,Monotard, Insulin Novo,Novo Monotard, Insulin

Related Publications

M I DRURY
January 1956, Diabetes,
M I DRURY
November 1953, British medical journal,
M I DRURY
March 1964, Scottish medical journal,
M I DRURY
October 1954, Danish medical bulletin,
M I DRURY
June 1958, British medical journal,
M I DRURY
July 1957, Acta paediatrica,
M I DRURY
May 1959, The Illinois medical journal,
M I DRURY
March 1960, Revue medicale de Liege,
M I DRURY
November 1979, Revue medicale de Liege,
Copied contents to your clipboard!